Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment. The gene discussed is LMF2; the disease is early-onset autosomal dominant Alzheimer disease.